WINDLAS BIOTECH
Back to Cashflow Statement
|
WINDLAS BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹105 Cr | ₹68 Cr | ₹109 Cr | ₹61 Cr | ₹9.13 Cr |
What is the latest Cash Flow from Operating Activities ratio of WINDLAS BIOTECH ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹105 Cr |
| Mar2025 | ₹68 Cr |
| Mar2024 | ₹109 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹9.13 Cr |
How is Cash Flow from Operating Activities of WINDLAS BIOTECH Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹105 Cr | 53.89 | |
| Mar2025 | ₹68 Cr | -37.42 | |
| Mar2024 | ₹109 Cr | 78.73 | |
| Mar2023 | ₹61 Cr | 567.74 | |
| Mar2022 | ₹9.13 Cr | - | |
Compare Cash Flow from Operating Activities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,770.6 Cr | -1.4% | -0.5% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | -1.4% |
-0.5% |
-8% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses